It is ideal for adults with a BMI of 30 or higher, or 27 with an accompanying weight-related condition
A meta-analysis revealed that a 2.4 mg dose of semaglutide led to a reduction of 12.4 kg of body weight, while doses of 3.0 mg of liraglutide, 1.0 mg of semaglutide, and 1.8 mg of liraglutide led to reductions in body weight of 5.2 kg, 3.7 kg, and 1.8 kg, respectively
Other Wegovy side effects In addition to the common side effects listed earlier, Wegovy can also cause serious side effects, such as: Low blood sugar levels (hypoglycemia), especially if used with insulin or certain other diabetes medications Pancreatitis (inflammation of the pancreas) Gallbladder problems Diabetic retinopathy (eye damage from diabetes) Allergic reactions Kidney problems Increased heart rate Suicidal thoughts and behaviors Wegovy has a boxed warning, which is the most serious warning required by the FDA
BMI is positively associated with accelerated epigenetic aging in twin pairs discordant for body mass index
The weight loss numbers reported include the combined effect of the drug plus the lifestyle changes
